Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 918,070 | +918,070 | $0 | $68.50M | 10.89% | +$68.50M |
| LB Pharmaceuticals Inc(LBRX) | 0 | 1,404,779 | +1,404,779 | $0 | $53.86M | 8.56% | +$53.86M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 2,984,125 | +2,984,125 | $0 | $53.86M | 8.56% | +$53.86M |
| Alto Neuroscience, Inc.(ANRO) | 0 | 1,676,558 | +1,676,558 | $0 | $42.80M | 6.81% | +$42.80M |
| Alkermes plcSHS(ALKS) | 0 | 948,471 | +948,471 | $0 | $38.43M | 6.11% | +$38.43M |
| Entera Bio LtdSHS | 0 | 11,213,455 | +11,213,455 | $0 | $32.63M | 5.19% | +$32.63M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 354,816 | +354,816 | $0 | $31.24M | 4.97% | +$31.24M |
| Savara Inc.(SVRA) | 0 | 5,381,941 | +5,381,941 | $0 | $27.77M | 4.42% | +$27.77M |
| Zai Lab LimitedADR(ZLAB) | 0 | 1,042,158 | +1,042,158 | $0 | $27.45M | 4.36% | +$27.45M |
| Relmada Therapeutics Inc | 0 | 6,912,191 | +6,912,191 | $0 | $26.06M | 4.14% | +$26.06M |
| Vaxcyte, Inc.(PCVX) | 0 | 306,047 | +306,047 | $0 | $17.41M | 2.77% | +$17.41M |
| Obsidian Therapeutics Inc | 0 | 1,249,943 | +1,249,943 | $0 | $17.16M | 2.73% | +$17.16M |
| Enliven Therapeutics Inc | 0 | 329,006 | +329,006 | $0 | $15.08M | 2.40% | +$15.08M |
| Enanta Pharmaceuticals Inc | 0 | 1,088,731 | +1,088,731 | $0 | $14.35M | 2.28% | +$14.35M |
| Surrozen Inc | 0 | 432,040 | +432,040 | $0 | $13.90M | 2.21% | +$13.90M |
| Sagimet Biosciences IncCOM SER A | 0 | 1,400,000 | +1,400,000 | $0 | $13.83M | 2.20% | +$13.83M |
| Yarrow Bioscience Inc | 0 | 607,382 | +607,382 | $0 | $13.68M | 2.17% | +$13.68M |
| Inflarx Nv | 0 | 6,086,170 | +6,086,170 | $0 | $10.96M | 1.74% | +$10.96M |
| Korsana Biosciences Inc | 0 | 338,951 | +338,951 | $0 | $10.30M | 1.64% | +$10.30M |
| Perspective Therapeutics Inc | 0 | 3,693,931 | +3,693,931 | $0 | $10.16M | 1.62% | +$10.16M |
| An2 Therapeutics Inc | 0 | 1,752,011 | +1,752,011 | $0 | $9.32M | 1.48% | +$9.32M |
| Inhibikase Therapeutics Inc | 0 | 3,581,603 | +3,581,603 | $0 | $7.36M | 1.17% | +$7.36M |
| Sab Biotherapeutics Inc | 0 | 2,198,502 | +2,198,502 | $0 | $6.97M | 1.11% | +$6.97M |
| Century Therapeutics Inc | 0 | 4,059,054 | +4,059,054 | $0 | $6.94M | 1.10% | +$6.94M |
| Erasca, Inc.(ERAS) | 0 | 422,543 | +422,543 | $0 | $6.19M | 0.98% | +$6.19M |
| Achieve Life Science Inc | 0 | 736,637 | +736,637 | $0 | $5.96M | 0.95% | +$5.96M |
| Minerva Neurosciences Inc | 0 | 1,655,500 | +1,655,500 | $0 | $5.55M | 0.88% | +$5.55M |
| Research Alliance Corp IiiCL A ORD SHS CL A | 0 | 500,000 | +500,000 | $0 | $5.42M | 0.86% | +$5.42M |
| Research Alliance Corp IvCL A | 0 | 450,000 | +450,000 | $0 | $5.40M | 0.86% | +$5.40M |
| Helix Acquisition Corp IiiCL A | 0 | 500,000 | +500,000 | $0 | $5.31M | 0.84% | +$5.31M |
| Attovia Therapeutics Inc | 0 | 228,295 | +228,295 | $0 | $3.91M | 0.62% | +$3.91M |
| Alector Inc | 0 | 2,101,068 | +2,101,068 | $0 | $3.89M | 0.62% | +$3.89M |
| Tcgx Acquisition CorpCL A | 0 | 300,000 | +300,000 | $0 | $3.75M | 0.60% | +$3.75M |
| Lexeo Therapeutics Inc | 0 | 928,593 | +928,593 | $0 | $3.14M | 0.50% | +$3.14M |
| Alumis Inc | 0 | 392,574 | +392,574 | $0 | $2.90M | 0.46% | +$2.90M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 231,585 | +231,585 | $0 | $2.67M | 0.42% | +$2.67M |
| Jatt Ii Acquisition Corp | 0 | 160,000 | +160,000 | $0 | $1.80M | 0.29% | +$1.80M |
| Jatt Iii Acquisition Corp | 0 | 150,000 | +150,000 | $0 | $1.65M | 0.26% | +$1.65M |
| Leonabio Inc | 0 | 393,701 | +393,701 | $0 | $1.41M | 0.22% | +$1.41M |